Tenon Medical, Inc. 8-K

What Happened

• On July 10, 2026 Tenon Medical, Inc. (TNON) filed a Form 8-K reporting that, after receiving a Nasdaq notice dated May 21, 2026 that it was not in compliance with the minimum stockholders’ equity requirement, the company completed a public offering on July 1, 2026 selling $4.2 million of common stock and warrants. As a result of that Offering, Tenon believes it satisfies Nasdaq’s stockholders’ equity requirement as of July 10, 2026.

Key Details

• Nasdaq notice of non-compliance was dated May 21, 2026.
• Tenon sold $4.2 million of common stock and warrants in a public offering closed July 1, 2026.
• Company states it believes it meets Nasdaq’s minimum stockholders’ equity requirement as of July 10, 2026.
• Nasdaq will continue monitoring compliance; if Tenon is not in compliance at the time of its September 30, 2026 Form 10-Q, it may be subject to delisting.

Why It Matters

• For investors, this filing indicates Tenon has taken capital-raising action to address a Nasdaq listing deficiency and currently believes it meets the exchange’s equity requirement, which reduces the immediate risk of delisting.
• However, continued listing depends on demonstrated compliance at the next quarterly reporting date (Sept. 30, 2026). The company’s 8-K also includes standard forward-looking disclaimers noting risks that could affect future results.